Organ On A Chip Technology
The Quasi Vivo® system is an advanced interconnected cell culture flow system, engineered to provide in vivo like conditions for cell growth.
SAVING LIVES THROUGH BETTER SCIENCE™
Kirkstall Ltd. is a biotechnology company, operating within the global organ-on-a-chip market. Established in 2006, our aim is to satisfy the overwhelming need for more human relevant science, brought about by the failures of traditional in vitro research and animal research models.
Quasi Vivo® features in over 15 academic publications across a variety of publications. View more
Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections
Authors: Chandokar. et al., 2017.
Journal: Scientific Reports. 2017, August.
Symmetry-breaking in branching epithelia: cells on micro-patterns under flow challenge the hypothesis of positive feedback by a secreted autocrine inhibitor of motility.
Authors: Martin K. et al., 2017.
Journal: Journal of Anatomy. 2017 March.
From the Cover: Disease-Induced Disparities in Formation of the Nanoparticle-Biocorona and the Toxicological Consequences.
Authors: Shannahan, JH. et al., 2016
Journal: Toxicol Sci. 2016 Aug;152(2):406-16
Quasi Vivo® is commercially available and used in 70+ labs worldwide, below is a sample of case studies from selected users.
Dr Pascale V. Guillot
(University College London, UK)
Professor Jamie Davies
(University of Edinburgh, UK)
Dr Simon A. Whawell
(University of Sheffield, UK)
The Quasi Vivo® system is specifically designed for ease of use and adaptability.
There are 3 different chambers available, giving you a wide variety of applications, including but not limited to:
YEAR IN INDUSTRY: ELEANOR WHEELER I’m currently in my first month of my year in industry with Kirkstall which, despite living with partying students and battling the hill starts in my little car in Sheffield, I am thoroughly enjoying! I am an enthusiastic...read more
Lonza Expands Cell-Culture Portfolio with Quasi Vivo ® System Basel, Switzerland, 12 February 2018 – Today Lonza announced the latest addition to its cell-culture product portfolio – the Quasi Vivo System. The Quasi Vivo Device consists of an advanced,...read more
3rd Year BSc Project: "The development of a physiological relevant gastrointestinal human–microbe interface in a novel dual-flow bioreactor." The human microbiome consists of more than 1000 different bacterial species that play essential roles in growth...read more
Address: Kirkstall Ltd
3 Aspen Court
Centurion Business Park
Phone: + 44 (0) 1709 361 241
Business Hours: Monday to Friday 8:00am-5:00pm (GMT)